Clinical Trial Update: Nortriptyline and the Risk of Serious Adverse Events

View source ↗

Summary

This clinical trial update discusses the risk of serious adverse events associated with nortriptyline in individuals with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Nortriptyline (nortriptyline)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Chronic Kidney Disease | Status: COMPLETED